Protocol update and baseline characteristics for the TRIal to slow the Progression of Diabetes (TRIPOD) randomized controlled trial

BACKGROUND: Type 2 diabetes (T2D), a major risk factor for cardiovascular disease and other adverse health conditions, is on the rise in Singapore. TRIPOD is a randomized controlled trial aimed to determine whether complementing usual care with an evidence-based diabetes management package (DMP) —co...

Descripción completa

Detalles Bibliográficos
Autores principales: Bairavi, Joann, Gardner, Daphne Su-Lyn, Yeoh, Ester, Tham, Kwang Wei, Gandhi, Mihir, Tan, Ngiap Chuan, Lee, Phong Ching, Lim, Robyn Su May, Adamjee, Thofique, Cheung, Yin Bun, Bee, Yong Mong, Finkelstein, Eric Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Update
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647071/
https://www.ncbi.nlm.nih.gov/pubmed/37964330
http://dx.doi.org/10.1186/s13063-023-07770-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647071/
https://www.ncbi.nlm.nih.gov/pubmed/37964330
http://dx.doi.org/10.1186/s13063-023-07770-7

Ejemplares similares